NEXTPHARMA HOLDINGS LTD

Active London

Activities of other holding companies n.e.c.

2 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
N

NEXTPHARMA HOLDINGS LTD

Activities of other holding companies n.e.c.

Founded 20 Dec 2010 Active London, England 2 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

ISAAC BIDCO LIMITED 20 Dec 2010 — 12 Jul 2011
Accounts Submitted 4 Oct 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 6 Jan 2026 Next due 17 Jan 2027 7 months remaining
Net assets £313K £13K 2023 year on year
Total assets £313K £13K 2023 year on year
Total Liabilities £0
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

83 Victoria Street London SW1H 0HW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NEXTPHARMA HOLDINGS LTD (07474361), an active life sciences and medical technology company based in London, England. Incorporated 20 Dec 2010. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

N/A

Net Assets

£313.42k

Increased by £13.24k (+4%)

Total Liabilities

N/A

Turnover

N/A

Employees

2

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2011Private Equity
Investor 2Jun 2017Secondary

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Nextpharma Germany Bidco Gmbh
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Seamus Philip Fitzpatrick

British,irish

Active
Notified 2 Jan 2019
Residence United Kingdom
DOB November 1966
Nature of Control
  • Significant Influence Or Control

Marc J Leder

Ceased 31 Aug 2017

Ceased

Rodger R Krouse

Ceased 31 Aug 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Jan 2026Confirmation StatementConfirmation statement made on 3 Jan 2026 with no updates
24 Dec 2025OfficersAppointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025
3 Dec 2025OfficersTermination of Peter Arend William Burema as director on 1 Nov 2025
4 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
29 Jan 2025OfficersChange to director Mr Peter Arend William Burema on 27 Jan 2025
6 Jan 2026 Confirmation Statement

Confirmation statement made on 3 Jan 2026 with no updates

24 Dec 2025 Officers

Appointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025

3 Dec 2025 Officers

Termination of Peter Arend William Burema as director on 1 Nov 2025

4 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 Jan 2025 Officers

Change to director Mr Peter Arend William Burema on 27 Jan 2025

Recent Activity

Latest Activity

Confirmation statement made on 3 Jan 2026 with no updates

4 months ago on 6 Jan 2026

Appointment of Mr Ajeeth Kumar Enjeti as director on 1 Nov 2025

5 months ago on 24 Dec 2025

Termination of Peter Arend William Burema as director on 1 Nov 2025

5 months ago on 3 Dec 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 4 Oct 2025

Change to director Mr Peter Arend William Burema on 27 Jan 2025

1 years ago on 29 Jan 2025